chloroquine has been researched along with sbi-0206965 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Feng, F; He, S; Jiang, X; Li, Q; Lu, X; Qu, W; Sun, H | 1 |
| Bakas, NA; Brun, SN; Celeridad, M; Chaikuad, A; Cosford, NDP; Knapp, S; Lambert, LJ; Limpert, AS; Ren, H; Shaw, RJ; Sheffler, DJ; Tautz, L; Vamos, M; Wimer, CD | 1 |
1 review(s) available for chloroquine and sbi-0206965
| Article | Year |
|---|---|
Design of Small Molecule Autophagy Modulators: A Promising Druggable Strategy.
Topics: Animals; Autophagy; Drug Design; Humans; Small Molecule Libraries | 2018 |
1 other study(ies) available for chloroquine and sbi-0206965
| Article | Year |
|---|---|
Design, Synthesis, and Characterization of an Orally Active Dual-Specific ULK1/2 Autophagy Inhibitor that Synergizes with the PARP Inhibitor Olaparib for the Treatment of Triple-Negative Breast Cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Autophagy; Autophagy-Related Protein-1 Homolog; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Screening Assays, Antitumor; Drug Synergism; Female; HEK293 Cells; Humans; Intracellular Signaling Peptides and Proteins; Mice, Inbred C57BL; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Pyrimidines; Triple Negative Breast Neoplasms | 2020 |